Grace Therapeutics, Inc.
USD2.47
+0.06 (+2.49%)
CEO
Prashant Kohli
IPO Date
2012-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.38
Prev. Close
$2.41
Day Low
$2.33
Day High
$2.47
52W Low
$1.79
52W High
$5.18
Market Cap
$0.04B
Volume
0.12M
| 10,000 |
| $3.80 |
| 12 Jan 2026 | NEUGEBOREN EDWARD | director | A-Award | Acquired | 10,000 | $3.80 |
| 12 Jan 2026 | DAVIS A BRIAN | director | A-Award | Acquired | 10,000 | $3.80 |
| 13 May 2025 | NEUGEBOREN EDWARD | director | A-Award | Acquired | 10,000 | $2.72 |
| 13 May 2025 | DAVIS A BRIAN | director | A-Award | Acquired | 10,000 | $2.72 |
| 16 Apr 2025 | DelAversano Robert J | Principal Financial Officer | A-Award | Acquired | 20,130 | $2.08 |
| 16 Apr 2025 | Macdonald R. Loch | Chief Medical Officer | A-Award | Acquired | 40,000 | $2.08 |